Nel Moore

Nel Moore Email and Phone Number

Senior Consultant at FWEast Consulting @ CHAIN Biotechnology Ltd
marlow, buckinghamshire, united kingdom
Nel Moore's Location
Freshwater East, Wales, United Kingdom, United Kingdom
Nel Moore's Contact Details

Nel Moore work email

Nel Moore personal email

n/a
About Nel Moore

During my 21 years in the Pharmaceutical Industry I have gained wide experience in Global Research, Development, Commercialisation, Alliance management and Product Divestment. I employ an open, honest, pro-active and empowering leadership style, aimed at creating an environment, which encourages optimal development for patients, products, and staff. Together with a well established ability to lead complex cross functional teams, and acute analytical skills, I have the rounded skill set required to successfully lead high value programs through development, submission, approval, launch and commercialisation, as well as leading product divestments to small or larger companies.

Nel Moore's Current Company Details
CHAIN Biotechnology Ltd

Chain Biotechnology Ltd

View
Senior Consultant at FWEast Consulting
marlow, buckinghamshire, united kingdom
Website:
chainbiotech.com
Employees:
12
Nel Moore Work Experience Details
  • Chain Biotechnology Ltd
    Executive Chair
    Chain Biotechnology Ltd Aug 2024 - Present
  • Chain Biotechnology Ltd
    Chairman Of The Board
    Chain Biotechnology Ltd Mar 2019 - Present
  • Aston University
    Council Member
    Aston University Jun 2024 - Present
    Birmingham, England, United Kingdom
  • Fweast Consulting
    Senior Consultant With Extensive Experience In Global Drug Development And Product Divestments
    Fweast Consulting Jan 2018 - Present
    FWEast offers advice and support in key R&D areasStrategy: Creation and/or review of Product Strategies from Research, through to Development and LaunchPartnering: Building strong, collaborative relationships with small and large R&D partners to support the successfully execution of the joint development programs and/or the divestment of productsTeams: Creation and/or coaching of high performing and delivery focussed cross functional R&D teams
  • Carb-X
    Post-Approval Advisory Board
    Carb-X Mar 2018 - Present
    Boston, Massachusetts, United States
    CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria. With more than $500 million to invest, CARB-X funds the best science from around the world. The CARB-X portfolio is the world’s largest early development pipeline of new antibiotics, vaccines, rapid diagnostics and other products to prevent and treat life-threatening bacterial infections.
  • Phagomed Biopharma Gmbh
    Non Executive Director
    Phagomed Biopharma Gmbh Aug 2020 - Oct 2021
    Vienna, Austria
    PhagoMed is an Austrian biotech company that develops phage-based drugs to treat persistent bacterial infections. It’s lead program PM-477 is a phage-based lysin active against bacteria of the genus Gardnerella, the lead pathogen in Bacterial Vaginosis. It is being developed as a treatment for patients with recurrent and refractory Bacterial Vaginosis, an area of very high medical need where antibiotics do not work
  • Metalinear Limited
    Non-Executive Director
    Metalinear Limited Jan 2018 - May 2020
    Manchester, England, United Kingdom
  • Astrazeneca
    Vice President Development Antibiotics
    Astrazeneca Nov 2015 - Dec 2017
    Design, build and lead an autonomous Development organisation within AZ (~60 staff), as part of a semi-autonomous Antibiotics Business Unit. Providing all development requirements for a portfolio of four antibiotics in various stage of development and commercialisation. Portfolio Divestment: Following the acquisition of the antibiotic assets September 2016 by Pfizer maintained development momentum (and therefore value) of the portfolio, whilst transitioning products and development programs.
  • Astrazeneca
    Global Product Vice President - Infection
    Astrazeneca Apr 2010 - Dec 2017
    Global Product Leader accountable for Global Phase 3 Development, Submission and Launch of AstraZeneca’s key late stage Infection asset.
  • Astrazeneca
    Global Product Director - Established Oncology Brands
    Astrazeneca May 2009 - Mar 2010
    Global Product Leader accountable for Global Development, Submissions and Launch support of AstraZeneca’s Established Oncology portfolio
  • Astrazeneca
    Global Product Director - Emerging
    Astrazeneca Jan 2005 - Apr 2009
    Leader of cross functional early global development team accountable for taking early stage Oncology and Infection assets from Research in to Phase 1, 2 clinical development
  • Astrazeneca
    Director Of Biology : Respiratory And Inflammation
    Astrazeneca Nov 2000 - Nov 2004
    Leadership of Department of ~80 Respiratory and Inflammation Scientists, responsible for research portfolio and budget management, as well as maintain optimal alignment with other Respiratory and Inflammation Departments within AZ
  • Astrazeneca
    Research Leader : Respiratory & Inflammation
    Astrazeneca Sep 1996 - Oct 2000
    (increasing seniority from Associate Team leaders to Associate Director)Designed and led research programs in area of rheumatoid arthritis, Osteoarthritis and Transplantation. Moving assets from lead identification through to preclinical development
  • University Of Birmingham
    Research Fellow & Senior Research Fellow : T Cell Development/Immunology
    University Of Birmingham Jan 1989 - Aug 1995
    Birmingham, United Kingdom
    Research into the mechanisms of development of T-cells, using innovative and ground breaking in vitro models

Nel Moore Skills

Drug Development Pharmaceutical Industry Clinical Development Oncology Drug Discovery Medical Affairs Clinical Trials Market Access Biomarkers Regulatory Submissions Life Sciences Biotechnology Cross Functional Team Leadership R&d Regulatory Affairs Lifesciences Therapeutic Areas Pharmacology Cro Pharmacokinetics Gcp Clinical Research Infection Expertise Biopharmaceuticals Technology Transfer Pharmaceutical Sales Pharmacovigilance Business Development Divestment And Transition Leadership Immunology Expertise Linemanagement Management Infectious Diseases Product Launch Pharmaceutics Strategy Leadership Immunology Cell Biology U.s. Food And Drug Administration Inflammation Change Management Commercialization Validation

Nel Moore Education Details

  • Birmingham University
    Birmingham University
    Biochemistry
  • Birmingham University
    Birmingham University
    Medical Biochemistry

Frequently Asked Questions about Nel Moore

What company does Nel Moore work for?

Nel Moore works for Chain Biotechnology Ltd

What is Nel Moore's role at the current company?

Nel Moore's current role is Senior Consultant at FWEast Consulting.

What is Nel Moore's email address?

Nel Moore's email address is ne****@****eca.com

What schools did Nel Moore attend?

Nel Moore attended Birmingham University, Birmingham University.

What skills is Nel Moore known for?

Nel Moore has skills like Drug Development, Pharmaceutical Industry, Clinical Development, Oncology, Drug Discovery, Medical Affairs, Clinical Trials, Market Access, Biomarkers, Regulatory Submissions, Life Sciences, Biotechnology.

Who are Nel Moore's colleagues?

Nel Moore's colleagues are Jess Tyson Phd Mba Cmgr Fcmi, Jonathan Baker, Zahid Bashir, Mbbs, Msc Oncology.

Not the Nel Moore you were looking for?

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.